Skip to main content
Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · IEX Real-Time Price · USD
0.838
-0.023 (-2.64%)
At close: May 2, 2024, 4:00 PM
0.832
-0.006 (-0.72%)
Pre-market: May 3, 2024, 4:19 AM EDT

Sunshine Biopharma Revenue

In the year 2023, Sunshine Biopharma had annual revenue of $24.09M with 454.42% growth. Revenue in the quarter ending December 31, 2023 was $7.68M with 94.94% year-over-year growth.

Revenue (ttm)
$24.09M
Revenue Growth
+454.42%
P/S Ratio
0.03
Revenue / Employee
$547,563
Employees
44
Market Cap
832.92K USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202324.09M19.75M454.42%
Dec 31, 20224.35M4.12M1,802.41%
Dec 31, 2021228.43K157.02K219.88%
Dec 31, 202071.41K50.29K238.10%
Dec 31, 201921.12K--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20151.71K--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20120--
Dec 31, 20110--
Dec 31, 20100--
Jul 31, 20090--
Jul 31, 20080--
Jul 31, 20070--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SBFM News

More News